NEUROBiOGEN

본문 바로가기 주메뉴 바로가기

Comunications

NEUROBIOGEN has been working with an advisory network of researchers and clinical
experts specializing in brain & neurological diseases with long experience.

News

News
Notice

News

Here are news on NEUROBIOGEN (currently in Korean only).

NO	SUBJECT	DATE	VIEW
97	Neurobiogen "Phase 1 successful treatment for obesity and dementia...Application for Phase 2 of Q2".	2024. 03. 20	342
96	Neurobiogen, obesity treatment..."It's more effective and safer" than the mainstream GLP-1.	2024. 03. 20	310
95	Neurobiogen Succeeds in Phase 1 Clinical Trials for Dementia and Obesity Drugs..."Nothing is wrong with financing".	2024. 03. 20	318
94	Neurobiogen "Succeeds in Phase 1 Clinical Trials for Native Obesity Drugs..."Preparing for the 2nd Global Prize".	2024. 03. 20	306
93	Neurobiogen "Innovative Dementia and Obesity Treatment Phase 1 Successful..."Promoting joint development with global pharmaceutical companies".	2024. 03. 20	318
92	Neurobiogen 'Clinical Phase 1 Termination'...Proposing a New Paradigm for the Treatment of Dementia and Obesity.	2024. 03. 20	278
91	Neurobiogen "Confirms Safety in Phase 1 Clinical Trials for Native Obesity Drugs..."Look forward to winning the 2nd prize".	2024. 03. 20	318
90	[Life magazine's great day] Modern people's chronic disease, obesity! How can I get out of this?	2024. 02. 08	289
89	Neurobiogen "Innovation Cost If Phase 1 Clinical Success..."I'm in phase 2 next year".	2023. 12. 15	315
88	CNR Research Applies for Phase 2 Pre-IND of Multi-Race Clinical Trials for Dementia/Obesity Treatment.	2023. 10. 04	335

1 2 3 4 5